Celladon Gains $21.8M

La Jolla-based Celladon, a developer of treatments for heart failure and other cardiovascular diseases, has raised $21.8M out of a $24.6M funding round, according to a filing from the firm today. Details on the new funding round were not disclosed by the company. The firm now lists Enterprise Partners, Venrock, and Johnson & Johnson Development Corporation as investors in the company. More information »